Definitive Contract HHSN261201400008C

The National Cancer Institute (NCI) awarded a Firm Fixed Price Definitive Contract to Navipoint Genomics LLC, a minority-owned small business, under the SBIR Program Phase II. The contract, valued at $1,679,321.00, is for the development of cloud-based software to support the Cancer Research Data Commons project. This project aims to enable precision oncology by facilitating collaboration in the cloud. The contract has a completion date of May 31, 2025 and is set aside for small businesses.

This is a firm fixed-price delivery order awarded by the National Institutes of Health (NIH) National Cancer Institute (NCI) to The Broad Institute, Inc. (The Broad), a non-profit biomedical and genomic research organization, to provide DNA whole genome sequencing (WGS) services for new NCI Cancer Genomics Cloud (CGC) studies. The period of performance is September 1, 2020 to August 31, 2023, with a completion date of August 31, 2025. The award is fully funded and non-severable, with a...

The National Cancer Institute (NCI) awarded a $142,009.29 firm fixed-price purchase order contract to Fundacio Centre De Regulacio Genomica, a non-profit biomedical research institute, to perform targeted gene sequencing on samples collected by NCI's Division of Cancer Epidemiology and Genetics. This contract, which does not have a set-aside designation, is expected to be completed by June 2023. The contract was awarded in September 2021 under simplified acquisition procedures for commercial...

The Department of Health and Human Services, National Institutes of Health, National Cancer Institute (NCI) has awarded a $200,000 firm-fixed-price purchase order contract to Bostongene Corporation, a for-profit organization, to provide multi-omic analyses for the comprehensive interrogation of tumors using the Surgical Oncology Program's SMART system. This sole-source contract is related to a previous non-competitive procurement opportunity that was posted on August 12, 2022, with a response...

This federal contract award, valued at $166,819,979.48, was issued by the National Cancer Institute (NCI) to The Broad Institute, Inc. (doing business as Broad Institute of MIT and Harvard), a non-profit biomedical and genomic research organization. The contract is for the Sequencing for the Cancer Genome Atlas (TCGA) Program, which supports the generation and analysis of genomic data to advance cancer research. The Broad Institute will provide a range of scientific services, including...

This federal contract was awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), to Cellecta, Inc., a for-profit manufacturer of genomic research products and services. The $299,952 firm-fixed price contract is for "GENETIC ANALYSIS OF CTCS AT THE SINGLE-CELL LEVEL" and does not have a set-aside designation. Cellecta specializes in providing advanced genomic technologies, including CRISPR, RNAi, and other tools, to support biomedical...

This is a firm fixed-price delivery order contract awarded by the National Cancer Institute (NCI) to the University Health Network (UHN), doing business as the Toronto General And Western Hospital Foundation, to procure existing clinical and treatment data on at least 500 pediatric cancer patients treated with photon therapy since 2007. The contract, valued at $97,021.21, is part of the NCI's Cancer Genome Atlas (TCGA) program and will support the U.S. Pediatric Photon Therapy Comparison...

The Department of the Air Force Air Combat Command awarded a $124,588.79 firm fixed price delivery order to Genomic Health, Inc. for Oncotype DX cancer testing services during the ordering period from March 2023 through March 2024. Genomic Health is a subsidiary of Exact Sciences Corporation which will perform the testing through its laboratory services division Exact Sciences Laboratories. The delivery order was awarded without a set-aside designation to support the Air Force's cancer...

This SBIR Phase I contract was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute to Navipoint Genomics LLC, a minority-owned and Asian-Pacific American-owned limited liability company. The $251,927 firm-fixed-price contract is for the development of cloud-based software in support of the Cancer Research Data Commons. This contract was issued under the total small business set-aside NIH SBIR solicitation PHS-2020-1, which...

The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute awarded a $455,000.00 Firm Fixed Price Definitive Contract to Omicscraft LLC, a minority-owned, small disadvantaged business, for a cloud-based liquid-biopsy platform to support the Cancer Research Data Commons. This contract falls under the ISYSMET program, which focuses on the development of cloud-based pipelines for integrative analysis of multi-omics and imaging data. The...